ArticlePLoS neglected tropical diseases2025
Promising therapeutic efficacy of nitazoxanide-loaded zinc oxide nano-formula against intestinal and muscular phases of experimental trichinellosis.
Article in PLoS neglected tropical diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Assessment of the therapeutic efficacy of Holothuria polii extract during the muscular phase of Trichinella spiralis infection in albino mice.Scientific reports · 2026Article
- Modulation of Oxidative Stress, Inflammatory Cytokines, and Mucosal Immunity by Green Synthesized Zinc Nanoparticles in Giardia Infection in Mice.Acta parasitologica · 2026Article
- Strategic Preparedness of Broad-Spectrum Antivirals for Rapid Response Towards Next Pandemics.Small science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Trichinellosis is a ubiquitous parasitic infection caused by a zoonotic nematode known as Trichinella spiralis (T. spiralis). It starts with the adult worm in the intestinal phase and ends up with the larva reaching the muscles. The disease generally manifests with acute gastroenteritis; however, it may regrettably lead to life-threatening myositis, myocarditis and seizures. The commercially existing chemotherapeutic regimens have numerous drawbacks including severe adverse effects, high resistance rate, poor bioavailability and low efficiency towards the muscular stage. Consequently, the current study targeted the evaluation of nitazoxanide-loaded zinc oxide nanoparticles (NTZ-loaded ZnO NPs) used for the first time in the treatment of both the intestinal and muscular phases of trichinellosis in mice. Swiss Albino mice were orally infected by 250 T. spiralis larvae. The experimental animals were treated with the gold standard albendazole, NTZ, ZnO NPs as well as NTZ-loaded ZnO NPs. Parasitological, biochemical (creatine kinase, alanine transaminase, aspartate transaminase, alkaline phosphatase, malondialdehyde and nitric oxide), immunological (interleukins 2 and 4) and histopathological assessments were conducted. The parasitological results denoted that the mice treated with NTZ-loaded ZnO NPs revealed the uppermost significant drug efficacy (>97%) in both the intestinal and muscular phases indicating efficacious tissue penetration. Additionally, this group revealed the most profound amelioration of the biochemical and immunological markers as well as restoration of the histopathological picture. Conclusively, the present work implied a bird's eye view on the promising effectiveness of NTZ-loaded ZnO NPs in the treatment of murine trichinellosis relying on the anti-parasitic safe nature of the formulation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.